| Albany Molecular Research, Inc. | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (518) 512-2000 | |||
![]() |
info@amriglobal.com | |||
| Chemical manufacturer | ||||
| International Laboratory Limited | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (650) 278-9963 | |||
![]() |
admin@intlab.org | |||
| Chemical manufacturer since 2002 | ||||
| Matrix Scientific Inc. | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (803) 788-9494 | |||
![]() |
sales@matrixscientific.com | |||
| Chemical manufacturer | ||||
| OX CHEM | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (626) 461-2812 | |||
![]() |
sales@ox-chem.com | |||
| CRO since 2013 | ||||
| SL Drugs and Pharmaceuticals Pvt. Ltd. | India | Inquire | ||
|---|---|---|---|---|
![]() |
+91 (40) 6661-1133 | |||
![]() |
enquiry@sldrugs.com | |||
| Chemical distributor since 1999 | ||||
| TimTec | USA | Inquire | ||
|---|---|---|---|---|
![]() |
+1 (302) 292-8500 | |||
![]() |
info@timtec.com | |||
| Chemical manufacturer | ||||
| Zylexa Pharma Ltd. | UK | Inquire | ||
|---|---|---|---|---|
![]() |
+44 (845) 299-6009/ | |||
![]() |
sales@zylexa-pharma.com,enquiries@zylexa-pharma.com | |||
| Chemical manufacturer | ||||
| Name | 5-(4-methylpiperazin-1-yl)indan-1-one |
|---|---|
| Synonyms | 5-(4-Methylpiperazin-1-yl)-2,3-dihydro-1H-inden-1-one; 5-(4-METHYL-PIPERAZIN-1-YL)-INDAN-1-ONE; 5-(4-Methylpiperazino)indan-1-one |
| Molecular Structure | ![]() |
| Molecular Formula | C14H18N2O |
| Molecular Weight | 230.30 |
| CAS Registry Number | 866849-23-2 |
| SMILES | O=C3c1c(cc(cc1)N2CCN(C)CC2)CC3 |
| InChI | 1S/C14H18N2O/c1-15-6-8-16(9-7-15)12-3-4-13-11(10-12)2-5-14(13)17/h3-4,10H,2,5-9H2,1H3 |
| InChIKey | MDJSXMRCQTVKRY-UHFFFAOYSA-N |
| Density | 1.161g/cm3 (Cal.) |
|---|---|
| Boiling point | 405.474°C at 760 mmHg (Cal.) |
| Flash point | 185.278°C (Cal.) |
| Refractive index | 1.591 (Cal.) |
| Safety Description | IRRITANT |
|---|---|
| SDS | Available |
| Market Analysis Reports |
| List of Reports Available for 5-(4-methylpiperazin-1-yl)indan-1-one |